| Device Classification Name |
Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings
|
| 510(k) Number |
K223783 |
| Device Name |
cobas SARS-CoV-2 Nucleic acid test for use on the cobas Liat System |
| Applicant |
| Roche Molecular Systems, Inc. |
| 4300 Hacienda Dr. |
|
Pleasanton,
CA
94588
|
|
| Applicant Contact |
Aradhana Karthikeyan |
| Correspondent |
| Roche Molecular Systems, Inc. |
| 4300 Hacienda Dr. |
|
Pleasanton,
CA
94588
|
|
| Correspondent Contact |
Alicja Stradomska |
| Classification Product Code |
|
| Date Received | 12/16/2022 |
| Decision Date | 12/04/2023 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Microbiology
|
| 510k Review Panel |
Microbiology
|
| Summary |
Summary
|
| FDA Review |
Decision Summary
|
| Type |
Dual Track
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|